Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 Apr 9, 2021 09:24AM
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021 Jan 8, 2021 08:30AM
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021 Jan 8, 2021 08:30AM
Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020 Apr 8, 2020 08:30AM
Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020 Apr 8, 2020 08:30AM


Jan 9, 2020 08:00AM Vericel to Present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020
Apr 3, 2019 08:30AM Vericel to Present at Needham Healthcare Conference
Apr 3, 2019 08:30AM Vericel to Present at Needham Healthcare Conference
Feb 28, 2019 05:38AM Needham & Company Downgrades Vericel Corporation (VCEL) to Hold
Jan 11, 2019 12:12PM Vericel to Present at the 21st Annual Needham Growth Conference
Jan 11, 2019 12:12PM Vericel to Present at the 21st Annual Needham Growth Conference
Nov 6, 2018 12:43PM Vericel Corporation (VCEL) PT Raised to $18 at Needham & Company
Aug 7, 2018 09:14AM Vericel Corporation (VCEL) PT Lowered to $14 at Needham & Company, Keeps 'Buy'
Mar 13, 2018 05:00PM Vericel to Present at the 17th Annual Needham Healthcare Conference
Mar 6, 2018 09:28AM Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
Mar 5, 2018 03:28PM Vericel Corporation (VCEL) PT Raised to $15 at Needham & Company
Jan 10, 2018 08:00AM Vericel to Present at the 20th Annual Needham Growth Conference
Jan 10, 2018 08:00AM Vericel to Present at the 20th Annual Needham Growth Conference
Mar 28, 2017 08:00AM Vericel to Present at the 16th Annual Needham Healthcare Conference
Dec 14, 2016 03:39PM Vericel (VCEL) MACI Approval Puts Profitability Within Reach - Needham & Company
Apr 8, 2016 08:30AM Vericel to Present at 15th Annual Needham Healthcare Conference
Apr 5, 2016 07:10AM Needham & Company Maintains Bullish View on Vericel (VCEL) Following Ixmyelocel Data; Primary Endpoint 'Robust', Secondary 'Confounding'
Mar 11, 2016 10:51AM Notable Analyst Rating Changes 3/11: (HTZ) (FNSR) (CVE) Upgraded; (WSM) (NGL) (SGY) Downgraded
Mar 11, 2016 07:35AM Needham & Company Upgrades Vericel Corporation (VCEL) to Buy, $12 PT
Apr 8, 2015 04:01PM Vericel to Present at Needham Healthcare Conference
Apr 8, 2015 04:01PM Vericel to Present at Needham Healthcare Conference